These results suggest that TMS likely triggers Bax/PUMA/P53 signaling that contributes to intrinsic apoptosis while cotreatment with TRAIL and TMS likely induces extrinsic apoptotic cell death in osteosarcoma. Here, TNFSF10 is linked to osteosarcoma.